Clinical Trials Details

EA8192 (Urothelial)

A Phase II/III Trial of MEDI4736 (Durvalumab) and Chemotherapy for Patients with High Grade Upper Tract Urothelial Cancer prior to Nephroureterectomy

Objective

Key eligibility: High-grade upper tract urothelial proven by biopsy within 12 weeks; no small cell/neuroendocrine carcinoma; no mets. 

» Learn more about this trial

Clinical Trial Categories

  • Cancers and Other Neoplasms